Constellation Brands (NYSE: STZ) is gearing up to announce its financial results for the third quarter, with the report scheduled for release after the market closes on Wednesday, January 7, 2025. This upcoming announcement has prompted a flurry of activity among financial analysts, who have been busy updating their forecasts and price targets for the beverage alcohol giant. The consensus among experts suggests a potential dip in quarterly earnings per share compared to the prior year, yet a notable increase in revenue is also projected, highlighting a mixed but keenly watched outlook for the company's performance.
Market observers are keenly watching Constellation Brands' upcoming earnings, especially after the company's second-quarter performance exceeded expectations. The anticipation builds as analysts weigh in on the potential impact of various market dynamics on the company's profitability and sales. The insights from these financial professionals are crucial for investors looking to understand the nuanced financial landscape Constellation Brands operates within, providing a comprehensive picture of what to expect when the official figures are disclosed.
Following the encouraging second-quarter results, Constellation Brands saw its shares close at $141.17 on Friday, marking a 2.3% gain. This positive movement indicates investor confidence, albeit cautious, ahead of the next earnings call. The stock's performance reflects the market's reaction to recent financial disclosures and analyst re-evaluations, setting the stage for what could be a pivotal moment for the company's stock trajectory.
Several top analysts have recently adjusted their ratings and price targets for Constellation Brands. Piper Sandler's Michael Lavery, with a 63% accuracy rate, maintained a 'Neutral' rating but lowered the price target from $155 to $135 on November 21, 2025. Barclays analyst Lauren Lieberman, holding a 59% accuracy rate, kept an 'Equal-Weight' rating, reducing the price target from $150 to $147 on October 9, 2025. JP Morgan's Andrea Teixeira, at 58% accuracy, maintained a 'Neutral' rating, cutting her price target from $173 to $153 on October 8, 2025. Morgan Stanley's Dara Mohsenian, known for a 70% accuracy rate, reiterated an 'Equal-Weight' rating but significantly reduced the price target from $176 to $160 on October 7, 2025. Lastly, Goldman Sachs analyst Bonnie Herzog, with a 66% accuracy rate, maintained a 'Buy' rating despite reducing the price target from $196 to $168 on October 2, 2025. These revisions underscore a nuanced outlook, reflecting varying levels of optimism and caution among leading financial experts.
As Constellation Brands prepares to unveil its third-quarter earnings, the market remains focused on how these results will align with, or deviate from, the revised analyst expectations. The upcoming report is not just a reflection of past performance but also a critical indicator for future investment decisions, influencing perceptions of the company's stability and growth prospects in a dynamic economic environment.